Cargando…
The Autophagy Inhibitor Verteporfin Moderately Enhances the Antitumor Activity of Gemcitabine in a Pancreatic Ductal Adenocarcinoma Model
Pancreatic ductal adenocarcinoma (PDAC) is highly resistant to chemotherapy. It has been described as requiring elevated autophagy for growth and inhibiting autophagy has been proposed as a treatment strategy. To date, all preclinical reports and clinical trials investigating pharmacological inhibit...
Autores principales: | Donohue, Elizabeth, Thomas, Anitha, Maurer, Norbert, Manisali, Irina, Zeisser-Labouebe, Magali, Zisman, Natalia, Anderson, Hilary J., Ng, Sylvia S. W., Webb, Murray, Bally, Marcel, Roberge, Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781989/ https://www.ncbi.nlm.nih.gov/pubmed/24069069 http://dx.doi.org/10.7150/jca.7030 |
Ejemplares similares
-
Induction of Covalently Crosslinked p62 Oligomers with Reduced Binding to Polyubiquitinated Proteins by the Autophagy Inhibitor Verteporfin
por: Donohue, Elizabeth, et al.
Publicado: (2014) -
Challenges and Opportunities in the Oral Delivery of Recombinant Biologics
por: Masloh, Solene, et al.
Publicado: (2023) -
Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells
por: Kan, Shin, et al.
Publicado: (2015) -
Verteporfin, a suppressor of YAP–TEAD complex, presents promising antitumor properties on ovarian cancer
por: Feng, Juntao, et al.
Publicado: (2016) -
Photodynamic Therapy with Verteporfin for Corneal Neovascularization
por: Al-Torbak, Abdullah A.
Publicado: (2012)